Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Medicines · US (FDA)
Antibiotics

FDA 2005

Macrolides

Clarithromycin

Approved 31 May 2005OralTablet

The FDA lists this product in 37 strengths and forms.

Official labelAsk Osler about it

On this page

Composition
Strengths and forms
Official product information

The table holds no label text for this product yet, only the facts beside it. The official product information has the full text.

Composition

Active ingredients: CLARITHROMYCIN 500MG

Strengths and forms

The FDA lists each strength of a product separately; these pages share one label.

CLARITHROMYCIN 250MG · TabletANDA065155-001 · Discontinued
CLARITHROMYCIN 500MG · TabletThis page
CLARITHROMYCIN 500MG · TabletANDA202710-002 · Prescription
CLARITHROMYCIN 250MG · TabletANDA202710-001 · Prescription
CLARITHROMYCIN 500MG · Tablet, extended releaseANDA208987-001 · Prescription
CLARITHROMYCIN 500MG · TabletANDA065136-001 · Prescription
CLARITHROMYCIN 250MG · TabletANDA065137-001 · Discontinued
CLARITHROMYCIN 500MG · TabletANDA065137-002 · Discontinued
CLARITHROMYCIN 250MG · TabletANDA203584-001 · Prescription
CLARITHROMYCIN 500MG · TabletANDA203584-002 · Prescription
CLARITHROMYCIN 250MG · TabletANDA210459-001 · Prescription
CLARITHROMYCIN 500MG · Tablet

More in antibiotics

Loteprednol Etabonate and Tobramycinloteprednol etabonate · Suspension/drops
Minocycline HydrochlorideInjectable

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

ANDA210459-002 · Prescription

CLARITHROMYCIN 500MG · Tablet, extended releaseANDA065145-001 · Prescription

CLARITHROMYCIN 500MG · Tablet, extended releaseANDA065154-001 · Prescription

CLARITHROMYCIN 125MG/5ML · For suspensionANDA065283-002 · Prescription

CLARITHROMYCIN 250MG/5ML · For suspensionANDA065283-003 · Prescription

CLARITHROMYCIN 500MG · Tablet, extended releaseANDA203243-001 · Prescription

CLARITHROMYCIN 250MG/5ML · For suspensionANDA065382-002 · Discontinued

CLARITHROMYCIN 125MG/5ML · For suspensionANDA065382-001 · Discontinued

CLARITHROMYCIN 500MG · Tablet, extended releaseANDA202532-001 · Discontinued

CLARITHROMYCIN 250MG · TabletANDA065174-001 · Discontinued

CLARITHROMYCIN 500MG · TabletANDA065174-002 · Discontinued

CLARITHROMYCIN 500MG · TabletANDA065178-001 · Discontinued

CLARITHROMYCIN 250MG · TabletANDA065178-002 · Discontinued

CLARITHROMYCIN 250MG · TabletANDA065266-001 · Discontinued

CLARITHROMYCIN 500MG · TabletANDA065266-002 · Discontinued

CLARITHROMYCIN 250MG · TabletANDA206714-001 · Discontinued

CLARITHROMYCIN 500MG · TabletANDA206714-002 · Discontinued

CLARITHROMYCIN 250MG · TabletANDA065144-001 · Prescription

CLARITHROMYCIN 500MG · TabletANDA065489-002 · Prescription

CLARITHROMYCIN 250MG · TabletANDA065489-001 · Prescription

CLARITHROMYCIN 500MG · TabletANDA065195-002 · Discontinued

CLARITHROMYCIN 250MG · TabletANDA065195-001 · Discontinued

CLARITHROMYCIN 1GM · Tablet, extended releaseANDA065210-001 · Discontinued

CLARITHROMYCIN 250MG · TabletANDA065384-001 · Prescription

CLARITHROMYCIN 500MG · TabletANDA065384-002 · Prescription

CLARITHROMYCIN 500MG · Tablet, extended releaseANDA065250-001 · Discontinued

Official product information

Drugs@FDA lists the approved labels, letters and reviews for application ANDA065155.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Brand name: Clarithromycin
Drug class: Macrolides
Group: Antibiotics
Route: Oral
Dosage form: Tablet
Applicant: Teva
Status: Discontinued
FDA approval: 31 May 2005
Application: ANDA065155-002
RxCUI: 21212

Guidelines

Guidelines in infectious diseases1,342 guidelines in the library

FDA 2024

Ciprofloxacin HydrochlorideSolution/drops

FDA 2024Pivyapivmecillinam hydrochloride · Tablet

FDA 2024FidaxomicinTablet

FDA 2023Likmezmetronidazole · Suspension

FDA 2023Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloridebismuth subcitrate potassium · Capsule

FDA 2022Voquezna Dual Pakamoxicillin · Capsule, tablet

FDA 2021FexinidazoleTablet

FDA 2019ErythromycinTablet, delayed release

FDA 2018Nuzyraomadacycline tosylate · Powder

FDA 2018Arikayce Kitamikacin sulfate · Suspension, liposomal

FDA 2018Cefepime Hydrochloride in Plastic Containercefepime hydrochloride · Powder

FDA 2018Ertapenem SodiumInjectable

FDA 2017Solosecsecnidazole · Granule

FDA 2017Baxdeladelafloxacin meglumine · Tablet

FDA 2017Moxifloxacin Hydrochloride in Sodium Chloride 0.8% in Plastic Containermoxifloxacin hydrochloride · Solution

FDA 2016Zenavoddoxycycline · Capsule